Telix Pharmaceuticals Limited
USD11.54
+0.24 (+2.12%)
CEO
Christian Behrenbruch
IPO Date
2024-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
Open
$11.30
Prev. Close
$11.30
Day Low
$11.30
Day High
$11.55
52W Low
$6.28
52W High
$16.98
Market Cap
$3.91B
Volume
0.07M
| 163.3 |
| 31 Dec 2023 | FY | 62.6% | 1.0% | 3.5% | 1.3% | 0.12 | 1.48 | 617.4 |
| 31 Dec 2022 | FY | 18.3% | -65.0% | -130.1% | -40.8% | 0.13 | 2.02 | -21.7 |
| 31 Dec 2021 | FY | -391.9% | -1059.9% | -3730.8% | -73.3% | 1.18 | 1.25 | -27.2 |
| 31 Dec 2020 | FY | 61.2% | -861.1% | -56.8% | -28.4% | 0.03 | 4.69 | -21.7 |
| 31 Dec 2019 | FY | -340.7% | -799.6% | -39.8% | -27.2% | 0.03 | 5.52 | -13.0 |
| 31 Dec 2018 | FY | 100.0% | -7087.1% | -26.1% | -18.0% | 0.03 | 4.35 | -9.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -12.9% | -12.5% | 0.01 | 33.74 | -12.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -2239.9 |
| -591.1 |
| 31 Dec 2024 | Q4 | 64.9% | 3.4% | 3.6% | 1.3% | 1.02 | 2.78 | 100.6 |
| 30 Jun 2024 | Q2 | 65.6% | 6.2% | 2.9% | 1.6% | 0.06 | 0.99 | 129.4 |
| 31 Dec 2023 | Q4 | 79.5% | 6.9% | 13.1% | 4.9% | 0.12 | 1.43 | 41.8 |
| 30 Jun 2023 | Q2 | 41.1% | -6.5% | -18.8% | -4.6% | 0.17 | 1.54 | -62.2 |
| 31 Dec 2022 | Q4 | 33.0% | -24.4% | -41.5% | -13.0% | 0.13 | 2.02 | -17.3 |
| 30 Jun 2022 | Q2 | -64.8% | -294.8% | -67.3% | -32.8% | 0.02 | 3.21 | -4.9 |
| 31 Dec 2021 | Q4 | -402.4% | -1024.2% | -2224.1% | -43.7% | 1.18 | 1.25 | -11.4 |
| 30 Jun 2021 | Q2 | -384.1% | -1117.3% | -67.8% | -25.2% | 0.04 | 3.15 | -13.2 |